Episode Details
Back to Episodes
Expert Insight on Key Data From WCLC 2020 in Early-Stage Lung Cancer
Description
In this episode, Jamie E. Chaft, MD, provides her expert perspective on new data from WCLC 2020 in early-stage NSCLC, with topics including:
- Updated results from ADAURA on HRQoL and DFS outcomes with or without postoperative chemotherapy after adjuvant osimertinib
- An analysis of the ongoing ITACA study of personalizing chemotherapy based on biomarkers of drug resistance
- FDG PET/CT adaptive radiotherapy in RTOG 1106
- The TALENT study in Taiwan screening nonsmokers for lung cancer
Presenter:
Jamie E. Chaft, MD
Associate Attending Physician
Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
New York, New York
Content supported by educational grants from Amgen; Bristol-Myers Squibb; Ipsen Biopharmaceuticals; Janssen Pharmaceutica NV; Jazz Pharmaceuticals; Regeneron Pharmaceuticals, Inc. & Sanofi Genzyme; and Takeda Oncology.
Link to full program, including a downloadable highlights slideset, and ClinicalThought commentaries:
http://bit.ly/2NzE6X6
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.